Crescent Biopharma, Inc.CBIONASDAQ
Loading
Total Costs & Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+47.3%
5Y CAGR+19.7%
Studio
Year-over-Year Change

Total of all costs and expenses

3Y CAGR
+47.3%/yr
vs -2.0%/yr prior
5Y CAGR
+19.7%/yr
Recent acceleration
Acceleration
+49.3pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.5x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$151.65M+120.5%
2024$68.76M+75.0%
2023$39.29M-17.3%
2022$47.48M-26.5%
2021$64.61M+4.8%
2020$61.67M+0.5%
2019$61.39M+19.2%
2018$51.51M+51.8%
2017$33.93M+6.3%
2016$31.93M-